These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA. Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K Circulation; 1998 Feb; 97(6):589-95. PubMed ID: 9494030 [TBL] [Abstract][Full Text] [Related]
8. Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats. Ko FN Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1274-82. PubMed ID: 9261257 [TBL] [Abstract][Full Text] [Related]
9. Iloprost-induced inhibition of proliferation of coronary artery smooth muscle cells is abolished by homologous desensitization. Grosser T; Bönisch D; Zucker TP; Schrör K Agents Actions Suppl; 1995; 45():85-91. PubMed ID: 7536386 [TBL] [Abstract][Full Text] [Related]
10. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Pakala R; Willerson JT; Benedict CR Circulation; 1997 Oct; 96(7):2280-6. PubMed ID: 9337201 [TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade. Yang Z; Krasnici N; Lüscher TF Circulation; 1999 Jul; 100(1):5-8. PubMed ID: 10393673 [TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. Yang Z; Noll G; Lüscher TF Circulation; 1993 Sep; 88(3):832-6. PubMed ID: 8353912 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 and vascular smooth muscle cell proliferation. Sachinidis A; Flesch M; Ko Y; Schrör K; Böhm M; Düsing R; Vetter H Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017 [TBL] [Abstract][Full Text] [Related]
14. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Masuda A; Mais DE; Oatis JE; Halushka PV Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482 [TBL] [Abstract][Full Text] [Related]
15. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro. O'Keefe EH; Liu EC; Greenberg R; Ogletree ML Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501 [TBL] [Abstract][Full Text] [Related]
16. Proliferative response of human and minipig smooth muscle cells after coronary angioplasty to growth factors and platelets. Unterberg C; Meyer T; Wiegand V; Kreuzer H; Buchwald AB Basic Res Cardiol; 1996; 91(6):407-17. PubMed ID: 8996625 [TBL] [Abstract][Full Text] [Related]
17. High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1. Little PJ; Allen TJ; Hashimura K; Nigro J; Farrelly CA; Dilley RJ Diabetes Res Clin Pract; 2003 Feb; 59(2):93-101. PubMed ID: 12560158 [TBL] [Abstract][Full Text] [Related]
18. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors. Dorn GW Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Watanabe S; Matsuda A; Suzuki Y; Kondo K; Ikeda Y; Hashimoto H; Umemura K Br J Pharmacol; 2000 May; 130(2):307-14. PubMed ID: 10807667 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells. Morinelli TA; Finley EL; Jaffa AA; Kurtz DT; Ullian ME Biochem Pharmacol; 1997 Jun; 53(12):1823-32. PubMed ID: 9256157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]